Daily Archives: January 6, 2022

Off-the-shelf PSCA-directed chimeric antigen receptor natural killer cell therapy to treat pancreatic cancer

Posted on January 6, 2022 by Gastroenterology Journal

Pancreatic cancer (PC) is the third leading cause of cancer-related death with a 5-year survival rate of approximately 10%. It typically presents as a late-stage incurable cancer and chemotherapy provides modest benefit. Here, we demonstrate the feasib… Continue reading →

Posted in News | Comments Off on Off-the-shelf PSCA-directed chimeric antigen receptor natural killer cell therapy to treat pancreatic cancer

Early life: an important window of susceptibility for colorectal cancer

Posted on January 6, 2022 by Gastroenterology Journal
Posted in News | Comments Off on Early life: an important window of susceptibility for colorectal cancer